Die letzte Seite des #Pharma-Briefes widmet sich wie immer einigen spannenden "Aus aller #Welt"-Themen 🌐
#Noma #GFINDER #research and #development & #homoopathie
...die nächste Ausgabe erscheint zusammen mit einem Pharmabrief-Spezial zu #NTDs und geht im April in den Druck 📚👏🎈
RT @dsw_intl: The EU reached record high investment in poverty-related & neglected diseases R&I 🔬 in 2021 according to new #GFINDER - a real cause for celebration! 👏 As global funding stagnates, we hope to see 🇪🇺 continue to lead & deliver on its #GlobalHealthStrategy! #beatNTDs! 🪱🦟🦠
🐦🔗: https://n.respublicae.eu/linagalvezmunoz/status/1622908460592427013
RT @dsw_intl: The EU reached record high investment in poverty-related & neglected diseases R&I 🔬 in 2021 according to new #GFINDER - a real cause for celebration! 👏 As global funding stagnates, we hope to see 🇪🇺 continue to lead & deliver on its #GlobalHealthStrategy! #beatNTDs! 🪱🦟🦠
🐦🔗: https://n.respublicae.eu/mgracacarvalho/status/1620447837199941632
BUKO Pharma-Kampagne
Lina Gálvez Muñoz
Maria Graça Carvalho